Trial Profile
A Study to Evaluate the Efficacy and Predictors of Response to Fingolimod in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2020
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 25 Feb 2016 New trial record